Related Experiment Video
Updated: Aug 26, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
[Prevalence of hepatitis C virus infection in different groups of selected populations]
P Bellissima1, S Bonfante, A Petralia
1Divisione Malattie Infettive, Azienda Ospedaliera Gravina, Caltagirone (CT).
Insights
Hepatitis C virus (HCV) prevalence is significant among drug users (68.44%), hemodialysis patients (58.55%), and thalassaemics (67.50%). Drug abuse, hemodialysis, and blood transfusions are key risk factors for HCV infection.
Area of Science:
- Virology
- Epidemiology
- Public Health
Context:
- Hepatitis C virus (HCV) poses a significant global health challenge.
- Understanding HCV prevalence and risk factors in specific populations is crucial for targeted interventions.
- This study focuses on the Caltagirone (CT) region, examining diverse risk groups.
Purpose:
- To determine the prevalence of Hepatitis C virus (HCV) infection.
- To identify key risk factors associated with HCV transmission in the studied populations.
- To explore the correlation between HCV infection and liver function.
Summary:
- Anti-HCV antibodies were detected in 0.64% of blood donors, 68.44% of drug users, 58.55% of hemodialysis patients, and 67.50% of thalassaemics.
- Major identified risk factors for HCV infection include drug abuse, undergoing hemodialysis, and history of blood transfusions.
- The study highlights significant HCV burden in specific high-risk groups within the Caltagirone region.
Impact:
- Provides crucial epidemiological data on HCV prevalence in specific risk groups.
- Informs public health strategies for HCV prevention and control.
- Highlights the importance of screening and risk factor management in vulnerable populations.
Abstract:
The objective of this study to determine the prevalence of hepatitis C virus at Caltagirone (CT) among blood donors, health care workers, drug users, hemodialysis patients and thalassaemics. The identification of risk factors for HCV infection and liver function in HCV correlate hepatitis. Anti-hepatitis C virus antibodies were detected in 0.64% of blood donors, in 68.44% of drug users, in 58.55% hemodialysis patients and in 67.50% of thalassaemics. Drug abuse, haemodialysis, blood transfusions are the major risk factors for hepatitis C.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Human Virome
Genital Herpes
Infectious Diseases and Their Occurrence
Inhibitors of Viral Protein Synthesis
